Index of reports
> Cases with Graft Versus Host Disease (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mycamine (Micafungin) where reactions include graft versus host disease. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mycamine side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-29
Patient: male, weighing 93.0 kg (204.6 pounds)
Reactions: Off Label Use, Graft Versus Host Disease, Device Related Infection, Infection
Drug(s) suspected as cause:
Prograf
Dosage: 13 mg, uid/qd
Administration route: Oral
Indication: Stem Cell Transplant
Start date: 2009-06-09
Mycamine
Dosage: unk
Indication: Antifungal Prophylaxis
Start date: 2009-08-01
Other drugs received by patient: Insulin; Antihypertensives; Actigall; Metrol; Vitamin D; Norvasc; Corticosteroids; Folic Acid
Possible Mycamine side effects in female
Reported by a physician from France on 2011-10-20
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Capillary Leak Syndrome, Bronchopulmonary Aspergillosis, Enterococcal Sepsis, Graft Versus Host Disease
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Mycamine
Other drugs received by patient: Mycophenolate Mofetil (Cellcept); Norepinephrine Bitartrate; Piperacillin and Tazobactam; Levofloxacin; Solu-Medrol; Solu-Medrol
|